Safety of Intravitreal Injections in Patients Receiving Warfarin Anticoagulation

American Journal of Ophthalmology

Volumn 144, Issue 3, 2007, Pages 451-453

  Dayani, Pouya N ^a   Siddiqi, Omar K ^a   Holekamp, Nancy M ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES RETINA INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; PEGAPTANIB; PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING DISORDER; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; RISK ASSESSMENT; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTICOAGULANTS; APTAMERS, NUCLEOTIDE; ASPIRIN; CHOROIDAL NEOVASCULARIZATION; DRUG THERAPY, COMBINATION; EYE HEMORRHAGE; FEMALE; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PYRAZOLES; RETROSPECTIVE STUDIES; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY; WARFARIN;

EID: 34548273012     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.05.006     Document Type: Article

References (3)

1. Poller L., and Thomson J. Evidence for "rebounds" hypercoagulability after stopping anticoagulants. Lancet 39 (1964) 62-64
2. Palareti G., Legnani C., Guazzaloca G., et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants: a prospective study. Thromb Haemost 72 (1994) 222-226
3. Genewin U., Haeberli A., Straub P.W., et al. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 92 (1996) 479-485